209 related articles for article (PubMed ID: 22350414)
1. MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.
Zhang P; Bill K; Liu J; Young E; Peng T; Bolshakov S; Hoffman A; Song Y; Demicco EG; Terrada DL; Creighton CJ; Anderson ML; Lazar AJ; Calin GG; Pollock RE; Lev D
Cancer Res; 2012 Apr; 72(7):1751-62. PubMed ID: 22350414
[TBL] [Abstract][Full Text] [Related]
2. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
[TBL] [Abstract][Full Text] [Related]
3. miR-193b-Regulated Signaling Networks Serve as Tumor Suppressors in Liposarcoma and Promote Adipogenesis in Adipose-Derived Stem Cells.
Mazzu YZ; Hu Y; Soni RK; Mojica KM; Qin LX; Agius P; Waxman ZM; Mihailovic A; Socci ND; Hendrickson RC; Tuschl T; Singer S
Cancer Res; 2017 Nov; 77(21):5728-5740. PubMed ID: 28882999
[TBL] [Abstract][Full Text] [Related]
4. Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma.
Ugras S; Brill E; Jacobsen A; Hafner M; Socci ND; Decarolis PL; Khanin R; O'Connor R; Mihailovic A; Taylor BS; Sheridan R; Gimble JM; Viale A; Crago A; Antonescu CR; Sander C; Tuschl T; Singer S
Cancer Res; 2011 Sep; 71(17):5659-69. PubMed ID: 21693658
[TBL] [Abstract][Full Text] [Related]
5. miR-193b regulates tumorigenesis in liposarcoma cells via PDGFR, TGFβ, and Wnt signaling.
Mazzu YZ; Hu Y; Shen Y; Tuschl T; Singer S
Sci Rep; 2019 Mar; 9(1):3197. PubMed ID: 30824765
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.
Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; Smid M; van Ijcken WF; Coindre JM; Chibon F; Verhoef C; Mathijssen RH; den Bakker MA; Verweij J; Sleijfer S; Wiemer EA
Int J Cancer; 2014 Jul; 135(2):348-61. PubMed ID: 24375455
[TBL] [Abstract][Full Text] [Related]
7. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.
Saydam O; Shen Y; Würdinger T; Senol O; Boke E; James MF; Tannous BA; Stemmer-Rachamimov AO; Yi M; Stephens RM; Fraefel C; Gusella JF; Krichevsky AM; Breakefield XO
Mol Cell Biol; 2009 Nov; 29(21):5923-40. PubMed ID: 19703993
[TBL] [Abstract][Full Text] [Related]
8. MiR-9-5p promotes MSC migration by activating β-catenin signaling pathway.
Li X; He L; Yue Q; Lu J; Kang N; Xu X; Wang H; Zhang H
Am J Physiol Cell Physiol; 2017 Jul; 313(1):C80-C93. PubMed ID: 28424168
[TBL] [Abstract][Full Text] [Related]
9. Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis.
Kapodistrias N; Mavridis K; Batistatou A; Gogou P; Karavasilis V; Sainis I; Briasoulis E; Scorilas A
Oncotarget; 2017 Jan; 8(4):6896-6913. PubMed ID: 28036291
[TBL] [Abstract][Full Text] [Related]
10. Whole blood miRNA expression analysis reveals miR-3613-3p as a potential biomarker for dedifferentiated liposarcoma.
Fricke A; Cimniak AFV; Ullrich PV; Becherer C; Bickert C; Pfeifer D; Heinz J; Stark GB; Bannasch H; Braig D; Eisenhardt SU
Cancer Biomark; 2018; 22(2):199-207. PubMed ID: 29689704
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
Quan H; Li B; Yang J
Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma.
Zhuang L; Wang X; Wang Z; Ma X; Han B; Zou H; Wu Z; Dong S; Qu Z; Zang Y; Wu L
Cell Death Dis; 2017 May; 8(5):e2804. PubMed ID: 28518144
[TBL] [Abstract][Full Text] [Related]
14. RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway.
Sun J; Ma Q; Li B; Wang C; Mo L; Zhang X; Tang F; Wang Q; Yan X; Yao X; Wu Q; Shu C; Xiong J; Fan W; Wang J
Cell Death Dis; 2020 Oct; 11(10):890. PubMed ID: 33087705
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
16. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
Ren W; Wang D; Li C; Shu T; Zhang W; Fu X
Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050
[TBL] [Abstract][Full Text] [Related]
17. miR-197-3p Represses the Proliferation of Prostate Cancer by Regulating the VDAC1/AKT/β-catenin Signaling Axis.
Huang Q; Ma B; Su Y; Chan K; Qu H; Huang J; Wang D; Qiu J; Liu H; Yang X; Wang Z
Int J Biol Sci; 2020; 16(8):1417-1426. PubMed ID: 32210729
[TBL] [Abstract][Full Text] [Related]
18. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcoma.
Garg M; Kanojia D; Mayakonda A; Said JW; Doan NB; Chien W; Ganesan TS; Chuang LS; Venkatachalam N; Baloglu E; Shacham S; Kauffman M; Koeffler HP
Oncotarget; 2017 Jan; 8(5):7521-7532. PubMed ID: 27893412
[TBL] [Abstract][Full Text] [Related]
20. MiR-27a regulates Wnt/beta-catenin signaling through targeting SFRP1 in glioma.
Wang K; Xie D; Xie J; Wan Y; Ma L; Qi X; Yang S
Neuroreport; 2015 Aug; 26(12):695-702. PubMed ID: 26164457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]